Soma Sengupta, MD, PhD, FRCP
Soma completed her MD-PhD at the University of Cambridge, U.K. She received Membership in the Royal College of Physicians (U.K.) before moving to the U.S. for an internship in medicine; residency in Neurology, Beth Israel Deaconess Medical Center-Harvard; and clinical and research fellowships at Massachusetts General Hospital, Boston Children’s Hospital, Dana-Farber Cancer Institute, and Brigham and Women’s Hospital. Soma is board certified in Neurology and Neuro-Oncology and recently elected (2020) a Fellow of the Royal College of Physicians (FRCP).
Soma’s Post-doctoral research training included a fellowship at Yale with Prof. Carolyn Slayman (deceased); training in immunology research at the Cambridge Institute of Medical research (U.K.) with Dr. Paul Lehner; and training in pediatric brain tumor research with Drs. Scott Pomeroy at Boston Children’s Hospital and Frances Jensen (currently Chair, Dept. Neurology, Univ. of Pennsylvania).
Soma was an attending at BIDMC-Harvard in neuro-oncology before moving to Emory Univ. and the Winship Cancer Institute. She has a long-standing research interest in membrane transport proteins and a major part of her lab is studying such proteins as anti-cancer targets as well as their role in development of disparate cancers. Clinically, Soma manages adult brain tumors and adult survivors of pediatric brain cancers. She has a strong clinical interest in investigator-initiated trials, to bring much needed new treatments for these patient populations.
LinkedIn: Soma Sengupta LinkedIn
Daniel Pomeranz Krummel, PhD
Daniel completed his PhD at Yale under Prof. Sid Altman (Nobel in Chemistry, 1989). He pursued postgraduate training in x-ray crystallography of large macromolecular complexes at the Medical Research Council’s Laboratory of Molecular Biology in Cambridge, U.K. where he worked with Dr. Kiyoshi Nagai (deceased), with whom he collaborated to determine the first structure of a small nuclear RNA-protein complex (Pomeranz Krummel et al. Nature, 2009). He was most recently a faculty member at Emory Univ. at the Winship Cancer Institute before joining the Univ. Cincinnati (July 2019). Daniel has a long-standing research interest in gene expression mechanisms and collaborates closely with Dr. Sengupta in research on membrane transport proteins in cancer development and as anti-cancer targets.
LinkedIn: Daniel Pomeranz Krummel LinkedIn
Debanjan Bhattacharya, PhD
Debanjan completed his doctoral training in India at the University of Calcutta and a Post-doctoral Fellowship at the Winship Cancer Institute at Emory University. Debanjan has a long-standing interest in pediatric and adult brain tumors. He has particular interest in application of various murine models to study molecular neuro-oncology and drug efficacy.
LinkedIn: Debanjan Bhattacharya LinkedIn
Laura Kallay, PhD
Principle Research Assistant; Regulatory Affairs Specialist
Laura has extensive research experience in cell and molecular biology as well as genetics. Laura also has an interest in regulatory affairs and recently completed a master's degree in Regulatory Science from Johns Hopkins.
Clinical Research Associate
Stacey has worked at various institutions as a clinical research associate. Stacey works closely with Soma to initiate novel clinical trials to aid cancer patients.
Eashika is learning the ropes of making a lab highly organized and efficient, a "well oiled machine". Eashika also has interest in animal modeling to aid drug discovery/development.
Claire is in her second year of study for undergraduate degree in neurobiology. Claire is enthusiastic and is currently pursuing a pre-med track at Univ. Cincinnati.